The origin and global emergence of adamantane resistant A/H3N2 influenza viruses
Martha I Nelson1, Lone Simonsen, Cécile Viboud
1Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA. nelsonma@mail.nih.gov
Abstract:
Resistance to the adamantane class of antiviral drugs by human A/H3N2 influenza viruses currently exceeds 90% in the United States and multiple Asian countries. Adamantane resistance is associated with a single amino acid change (S31N) in the M2 protein, which was shown to rapidly disseminate globally in 2005 in association with a genome reassortment event. However, the exact origin of influenza A/H3N2 viruses carrying the S31N mutation has not been characterized, particularly in South-East Asia. We therefore conducted a phylogenetic analysis of the HA, NA, and M1/2 segments of viral isolates collected between 1997 and 2007 from temperate localities in the Northern hemisphere (New York State, United States, 492 isolates) and Southern hemisphere (New Zealand and Australia, 629 isolates) and a subtropical locality in South-East Asia (Hong Kong, 281 isolates). We find that although the S31N mutation was independently introduced at least 11 times, the vast majority of resistant viruses now circulating globally descend from a single introduction that was first detected in the summer of 2003 in Hong Kong. These resistant viruses were continually detected in Hong Kong throughout 2003-2005, acquired a novel HA through reassortment during the first part of 2005, and thereafter spread globally. The emergence and persistence of adamantane resistant viruses in Hong Kong further supports a source-sink model of global influenza virus ecology, in which South-East Asia experiences continuous viral activity and repeatedly seeds epidemics in temperate areas.
Insights
Most adamantane-resistant A/H3N2 influenza viruses globally originated from a single 2003 introduction in Hong Kong. This highlights Southeast Asia as a key source for global influenza virus evolution and spread.
Area of Science:
- Virology
- Molecular Epidemiology
- Antimicrobial Resistance
Background:
- High-level resistance (>90%) to adamantane antivirals in human A/H3N2 influenza viruses is prevalent in the US and Asia.
- Adamantane resistance is linked to the S31N mutation in the M2 protein, which spread globally after a 2005 reassortment event.
- The precise origin of S31N-mutated A/H3N2 viruses, especially in Southeast Asia, remains unclear.
Purpose of the Study:
- To investigate the origin and phylogenetic history of adamantane-resistant A/H3N2 influenza viruses.
- To characterize the dissemination of the S31N M2 mutation in influenza A/H3N2 viruses globally.
- To explore the role of Southeast Asia in the ecology and spread of influenza viruses.
Main Methods:
- Phylogenetic analysis of hemagglutinin (HA), neuraminidase (NA), and M1/M2 segments.
- Analysis of viral isolates collected between 1997 and 2007 from New York, New Zealand, Australia, and Hong Kong.
- Tracking the emergence and spread of the S31N mutation in the M2 protein.
Main Results:
- The S31N mutation was introduced independently at least 11 times.
- The majority of currently circulating resistant viruses trace back to a single introduction detected in Hong Kong in summer 2003.
- Resistant viruses persisted in Hong Kong (2003-2005), acquired a new HA via reassortment in early 2005, and then spread globally.
- Hong Kong served as the origin for the dominant global lineage of resistant A/H3N2 viruses.
Conclusions:
- Southeast Asia, specifically Hong Kong, is a critical origin point for the global spread of adamantane-resistant A/H3N2 influenza.
- The findings support a source-sink model of influenza virus ecology, where Southeast Asia repeatedly seeds epidemics in temperate regions.
- Understanding viral origins is crucial for predicting and controlling influenza pandemics.
Related Concept Videos
Influenza
Viral Mutations
Infectious Diseases and Their Occurrence
Inhibitors Of Virion Release
Viral Recombination
Leaky Scanning


